View in EDS

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Saved in:
Bibliographic Details
Title: Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).
Authors: Opdam M; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ultee N; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Geenen JJJ; Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum AGJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Data Center, Netherlands Cancer Institute, Amsterdam, the Netherlands., Balduzzi S; Biometrics Division, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hofland I; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, the Netherlands., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Menezes RX; Biostatistics Centre, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center, Utrecht, the Netherlands. Electronic address: s.linn@nki.nl.
Corporate Authors: MATADOR trialists' group for the Dutch Breast Cancer Research Group (BOOG)
Source: Breast (Edinburgh, Scotland) [Breast] 2026 Jun; Vol. 87, pp. 104749. Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3080
DOI:10.1016/j.breast.2026.104749